Cargando…

First person – Sara Ibrahim

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sara Ibrahim is first author on ‘A novel Cre-enabled tetracycline-inducible transgenic syst...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328170/
http://dx.doi.org/10.1242/dmm.045195
_version_ 1783552690599493632
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sara Ibrahim is first author on ‘A novel Cre-enabled tetracycline-inducible transgenic system for tissue-specific cytokine expression in the zebrafish: CETI-PIC3’, published in DMM. Sara is an MD-PhD student in the lab of Emily K. Sims and Ryan M. Anderson at Indiana University School of Medicine, Indianapolis, IN, USA, developing and utilizing molecular biology techniques to study β cell dysfunction.
format Online
Article
Text
id pubmed-7328170
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-73281702020-07-01 First person – Sara Ibrahim Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sara Ibrahim is first author on ‘A novel Cre-enabled tetracycline-inducible transgenic system for tissue-specific cytokine expression in the zebrafish: CETI-PIC3’, published in DMM. Sara is an MD-PhD student in the lab of Emily K. Sims and Ryan M. Anderson at Indiana University School of Medicine, Indianapolis, IN, USA, developing and utilizing molecular biology techniques to study β cell dysfunction. The Company of Biologists Ltd 2020-06-26 /pmc/articles/PMC7328170/ http://dx.doi.org/10.1242/dmm.045195 Text en © 2020. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Sara Ibrahim
title First person – Sara Ibrahim
title_full First person – Sara Ibrahim
title_fullStr First person – Sara Ibrahim
title_full_unstemmed First person – Sara Ibrahim
title_short First person – Sara Ibrahim
title_sort first person – sara ibrahim
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328170/
http://dx.doi.org/10.1242/dmm.045195